Metraipolis › archive › dc_9b1316ffcd53

Perfusion development and its potential for cell therapy manufacturing with adherent cells — Europe PMC PMID:42397589

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42397589
DOI
10.1007/s00253-[numero omesso]-2
License (as archived)
solo-consultazione
Archived
2026-10-18T11:49:13.788Z
SHA-256 of the archived text
22b271b6bce6026dd8a19d62d0fb0c0bf74e2b87875c93ba9f689f4efc85416b
Stable URL of this page
https://metraipolis.com/documento/dc_9b1316ffcd53

How to cite

Perfusion development and its potential for cell therapy manufacturing with adherent cells — Europe PMC PMID:42397589 — Europe PMC (en), https://europepmc.org/article/MED/42397589 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9b1316ffcd53 (Metraipolis archive dc_9b1316ffcd53, sha256 22b271b6bce6026dd8a19d62d0fb0c0bf74e2b87875c93ba9f689f4efc85416b)
BibTeX
@misc{dc9b1316ffcd53,
  title = {Perfusion development and its potential for cell therapy manufacturing with adherent cells — Europe PMC PMID:42397589},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42397589},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9b1316ffcd53; sha256 22b271b6bce6026dd8a19d62d0fb0c0bf74e2b87875c93ba9f689f4efc85416b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42397589. Agents can read the archived copy with the MCP tool read_document.